Arterial levels and net hepatic balances of plasma NEFAs, 3-hydroxybutyrate, glycerol, lactate, and alanine before and after oral administration of BAY R 3401 in the presence of non-insulin-induced hypoglycemia with and without mild hyperinsulinemia and in the presence of the maintenance of euglycemia with and without mild hyperinsulinemia in 18-h-fasted conscious dogs
Group . | Control period . | BAY R 3401 with or without peripheral glucose infusion (min) . | . | . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | 10 . | 20 . | 30 . | 60 . | 90 . | 120 . | 180 . | ||||||
NEFA | ||||||||||||||
Hypoglycemia | ||||||||||||||
Plasma level (mmol/l) | 0.67 ± 0.04 | 0.68 ± 0.07 | 0.80 ± 0.07* | 0.92 ± 0.14* | 1.29 ± 0.23* | 1.39 ± 0.20* | 1.49 ± 0.15* | 1.52 ± 0.09* | ||||||
NHB (μmol · kg−1 · min−1) | −2.51 ± 0.32 | −2.51 ± 0.26 | −2.85 ± 0.26 | −3.22 ± 0.37* | −4.43 ± 0.90* | −5.32 ± 0.71* | −6.12 ± 0.74* | −6.69 ± 1.05* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Plasma level (mmol/l) | 0.82 ± 0.08 | 0.72 ± 0.09 | 0.53 ± 0.09 | 0.64 ± 0.10 | 0.73 ± 0.14 | 0.73 ± 0.14 | 0.79 ± 0.10 | 0.77 ± 0.164 | ||||||
NHB (μmol · kg−1 · min−1) | −3.18 ± 0.56 | −3.27 ± 0.40 | −1.95 ± 0.40 | −2.39 ± 0.20 | −3.20 ± 1.02 | −3.47 ± 0.54 | −2.90 ± 0.19 | −2.06 ± 0.61 | ||||||
Euglycemia | ||||||||||||||
Plasma level (mmol/l) | 0.79 ± 0.09 | 0.73 ± 0.08 | 0.81 ± 0.08 | 0.80 ± 0.10 | 0.84 ± 0.13 | 0.78 ± 0.12 | 0.82 ± 0.06 | 0.91 ± 0.06 | ||||||
NHB (μmol · kg−1 · min−1) | −1.83 ± 0.29 | −1.51 ± 0.35 | −1.43 ± 0.33 | −1.96 ± 0.33 | −2.06 ± 0.51 | −2.18 ± 0.39 | −2.32 ± 0.25 | −2.39 ± 0.24 | ||||||
Euglycemia + insulin | ||||||||||||||
Plasma level (mmol/l) | 0.65 ± 0.09 | 0.68 ± 0.09 | 0.56 ± 0.09 | 0.48 ± 0.08 | 0.34 ± 0.06* | 0.31 ± 0.05* | 0.33 ± 0.06* | 0.29 ± 0.06* | ||||||
NHB (μmol · kg−1 · min−1) | −1.65 ± 0.22 | −1.92 ± 0.27 | −1.44 ± 0.30 | −0.86 ± 0.24 | −0.71 ± 0.19* | −0.48 ± 0.18* | −0.73 ± 0.23* | −0.58 ± 0.17* | ||||||
3-Hydroxybutyrate | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 20 ± 3 | 19 ± 2 | 15 ± 2 | 16 ± 3 | 28 ± 4 | 49 ± 4* | 65 ± 7* | 111 ± 20* | ||||||
NHB (μmol · kg−1 · min−1) | 0.72 ± 0.14 | 0.64 ± 0.12 | 0.76 ± 0.12 | 0.66 ± 0.11 | 1.17 ± 0.17 | 1.93 ± 0.21* | 2.52 ± 0.47* | 3.91 ± 1.25* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 29 ± 8 | 21 ± 3 | 19 ± 3 | 14 ± 3 | 32 ± 15 | 32 ± 15 | 25 ± 9 | 24 ± 8 | ||||||
NHB (μmol · kg−1 · min−1) | 1.41 ± 0.45 | 0.75 ± 0.17 | 0.82 ± 0.17 | 0.87 ± 0.19 | 2.02 ± 0.89 | 1.69 ± 0.83 | 1.30 ± 0.62 | 1.86 ± 1.04 | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 33 ± 11 | 24 ± 6 | 27 ± 6 | 32 ± 3 | 24 ± 3 | 14 ± 1* | 17 ± 4 | 31 ± 15 | ||||||
NHB (μmol · kg−1 · min−1) | 1.06 ± 0.38 | 0.60 ± 0.1 | 0.94 ± 0.1 | 1.01 ± 0.08 | 1.10 ± 0.06 | 0.61 ± 0.05 | 0.90 ± 0.15 | 1.00 ± 0.33 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 19 ± 3 | 21 ± 3 | 14 ± 3 | 13 ± 3 | 5 ± 1* | 4 ± 1* | 6 ± 1* | 4 ± 2* | ||||||
NHB (μmol · kg−1 · min−1) | 0.60 ± 0.08 | 0.49 ± 0.04 | 0.54 ± 0.06 | 0.40 ± 0.03 | 0.27 ± 0.07* | 0.24 ± 0.03* | 0.23 ± 0.08* | 0.15 ± 0.07* | ||||||
Glycerol | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 63 ± 4 | 66 ± 5 | 77 ± 5* | 98 ± 12* | 107 ± 15* | 107 ± 12* | 119 ± 5* | 124 ± 11* | ||||||
NHB (μmol · kg−1 · min−1) | −1.12 ± 0.11 | −1.11 ± 0.11 | −1.63 ± 0.11* | −2.34 ± 0.56* | −2.39 ± 0.51* | −2.31 ± 0.43* | −2.68 ± 0.27* | −2.91 ± 0.50* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 88 ± 10 | 68 ± 9 | 57 ± 9 | 78 ± 6 | 92 ± 18 | 88 ± 6 | 105 ± 10 | 108 ± 9 | ||||||
NHB (μmol · kg−1 · min−1) | −2.20 ± 0.28 | −1.42 ± 0.21 | −1.49 ± 0.21 | −2.06 ± 0.34 | −2.60 ± 0.65 | −2.36 ± 0.28 | −2.88 ± 0.46 | −3.34 ± 0.61 | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 85 ± 5 | 74 ± 7 | 98 ± 7 | 73 ± 10 | 96 ± 7 | 92 ± 12 | 70 ± 8 | 78 ± 13 | ||||||
NHB (μmol · kg−1 · min−1) | −1.41 ± 0.14 | −1.29 ± 0.15 | −1.26 ± 0.15 | −1.35 ± 0.17 | −1.68 ± 0.10 | −1.63 ± 0.16 | −1.49 ± 0.19 | −1.45 ± 0.21 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 68 ± 7 | 51 ± 7 | 49 ± 8 | 45 ± 6* | 38 ± 7* | 36 ± 7* | 43 ± 7* | 53 ± 9* | ||||||
NHB (μmol · kg−1 · min−1) | −1.08 ± 0.20 | −0.78 ± 0.20 | −0.79 ± 0.19 | −0.61 ± 0.10 | −0.56 ± 0.04* | −0.52 ± 0.07* | −0.59 ± 0.13* | −0.78 ± 0.18* | ||||||
Lactate | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 632 ± 113 | 595 ± 65 | 522 ± 65 | 573 ± 53 | 479 ± 56 | 461 ± 44* | 467 ± 54* | 452 ± 42* | ||||||
NHB (μmol · kg−1 · min−1) | −1.18 ± 2.76 | −2.08 ± 2.67 | −2.44 ± 2.67 | −4.21 ± 1.78 | −4.37 ± 0.83* | −5.80 ± 1.39* | −7.62 ± 1.24* | −8.73 ± 1.36* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 716 ± 147 | 630 ± 129 | 616 ± 129 | 542 ± 109 | 464 ± 112 | 506 ± 129 | 619 ± 136 | 548 ± 52 | ||||||
NHB (μmol · kg−1 · min−1) | −2.09 ± 1.71 | −2.23 ± 1.19 | −3.84 ± 1.19 | −5.82 ± 2.76* | −5.45 ± 2.44* | −4.80 ± 1.32* | −6.56 ± 1.97* | −8.48 ± 2.22* | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 636 ± 81 | 647 ± 124 | 615 ± 124 | 536 ± 98 | 564 ± 91 | 548 ± 69 | 469 ± 71* | 430 ± 73* | ||||||
NHB (μmol · kg−1 · min−1) | −3.05 ± 2.69 | −1.27 ± 4.15 | −3.71 ± 4.15 | −3.40 ± 3.56 | −1.02 ± 2.23 | −2.44 ± 0.89 | −4.20 ± 0.27 | −5.47 ± 0.42 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 775 ± 120 | 700 ± 120 | 650 ± 80 | 560 ± 60 | 450 ± 40* | 370 ± 20* | 370 ± 30* | 420 ± 40* | ||||||
NHB (μmol · kg−1 · min−1) | 7.73 ± 4.55 | 2.51 ± 5.10 | 0.29 ± 3.24 | 1.99 ± 2.09 | 0.32 ± 1.09* | −0.96 ± 0.92* | −0.91 ± 0.56* | −1.87 ± 0.57* | ||||||
Alanine | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 317 ± 21 | 312 ± 21 | 301 ± 21 | 292 ± 13 | 270 ± 29 | 227 ± 27* | 206 ± 26* | 161 ± 26* | ||||||
NHB (μmol · kg−1 · min−1) | −1.99 ± 0.21 | −1.67 ± 0.23 | −2.37 ± 0.23 | −2.71 ± 0.22* | −2.97 ± 0.52* | −2.73 ± 0.36* | −2.97 ± 0.47* | −2.74 ± 0.54* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 340 ± 29 | 325 ± 33 | 312 ± 33 | 310 ± 40 | 254 ± 36* | 217 ± 30* | 198 ± 27* | 172 ± 17* | ||||||
NHB (μmol · kg−1 · min−1) | −2.75 ± 0.37 | −2.98 ± 0.58 | −2.79 ± 0.59 | −3.38 ± 0.70 | −3.23 ± 0.88 | −3.05 ± 0.73 | −2.87 ± 0.60 | −2.90 ± 0.52 | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 299 ± 25 | 290 ± 25 | 257 ± 25 | 253 ± 28 | 246 ± 25 | 245 ± 27 | 232 ± 35* | 204 ± 34* | ||||||
NHB (μmol · kg−1 · min−1) | −2.31 ± 0.32 | −2.12 ± 0.46 | −1.94 ± 0.46 | −2.33 ± 0.34 | −1.85 ± 0.27 | −2.02 ± 0.51 | −2.20 ± 0.37 | −1.99 ± 0.63 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 390 ± 45 | 370 ± 50 | 370 ± 50 | 330 ± 40 | 290 ± 30* | 210 ± 20* | 190 ± 20* | 170 ± 20* | ||||||
NHB (μmol · kg−1 · min−1) | −1.93 ± 0.39 | −2.23 ± 0.39 | −2.22 ± 0.41 | −2.04 ± 0.25 | −2.29 ± 0.43 | −1.73 ± 0.26 | −1.67 ± 0.20 | −1.65 ± 0.24 |
Group . | Control period . | BAY R 3401 with or without peripheral glucose infusion (min) . | . | . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | 10 . | 20 . | 30 . | 60 . | 90 . | 120 . | 180 . | ||||||
NEFA | ||||||||||||||
Hypoglycemia | ||||||||||||||
Plasma level (mmol/l) | 0.67 ± 0.04 | 0.68 ± 0.07 | 0.80 ± 0.07* | 0.92 ± 0.14* | 1.29 ± 0.23* | 1.39 ± 0.20* | 1.49 ± 0.15* | 1.52 ± 0.09* | ||||||
NHB (μmol · kg−1 · min−1) | −2.51 ± 0.32 | −2.51 ± 0.26 | −2.85 ± 0.26 | −3.22 ± 0.37* | −4.43 ± 0.90* | −5.32 ± 0.71* | −6.12 ± 0.74* | −6.69 ± 1.05* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Plasma level (mmol/l) | 0.82 ± 0.08 | 0.72 ± 0.09 | 0.53 ± 0.09 | 0.64 ± 0.10 | 0.73 ± 0.14 | 0.73 ± 0.14 | 0.79 ± 0.10 | 0.77 ± 0.164 | ||||||
NHB (μmol · kg−1 · min−1) | −3.18 ± 0.56 | −3.27 ± 0.40 | −1.95 ± 0.40 | −2.39 ± 0.20 | −3.20 ± 1.02 | −3.47 ± 0.54 | −2.90 ± 0.19 | −2.06 ± 0.61 | ||||||
Euglycemia | ||||||||||||||
Plasma level (mmol/l) | 0.79 ± 0.09 | 0.73 ± 0.08 | 0.81 ± 0.08 | 0.80 ± 0.10 | 0.84 ± 0.13 | 0.78 ± 0.12 | 0.82 ± 0.06 | 0.91 ± 0.06 | ||||||
NHB (μmol · kg−1 · min−1) | −1.83 ± 0.29 | −1.51 ± 0.35 | −1.43 ± 0.33 | −1.96 ± 0.33 | −2.06 ± 0.51 | −2.18 ± 0.39 | −2.32 ± 0.25 | −2.39 ± 0.24 | ||||||
Euglycemia + insulin | ||||||||||||||
Plasma level (mmol/l) | 0.65 ± 0.09 | 0.68 ± 0.09 | 0.56 ± 0.09 | 0.48 ± 0.08 | 0.34 ± 0.06* | 0.31 ± 0.05* | 0.33 ± 0.06* | 0.29 ± 0.06* | ||||||
NHB (μmol · kg−1 · min−1) | −1.65 ± 0.22 | −1.92 ± 0.27 | −1.44 ± 0.30 | −0.86 ± 0.24 | −0.71 ± 0.19* | −0.48 ± 0.18* | −0.73 ± 0.23* | −0.58 ± 0.17* | ||||||
3-Hydroxybutyrate | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 20 ± 3 | 19 ± 2 | 15 ± 2 | 16 ± 3 | 28 ± 4 | 49 ± 4* | 65 ± 7* | 111 ± 20* | ||||||
NHB (μmol · kg−1 · min−1) | 0.72 ± 0.14 | 0.64 ± 0.12 | 0.76 ± 0.12 | 0.66 ± 0.11 | 1.17 ± 0.17 | 1.93 ± 0.21* | 2.52 ± 0.47* | 3.91 ± 1.25* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 29 ± 8 | 21 ± 3 | 19 ± 3 | 14 ± 3 | 32 ± 15 | 32 ± 15 | 25 ± 9 | 24 ± 8 | ||||||
NHB (μmol · kg−1 · min−1) | 1.41 ± 0.45 | 0.75 ± 0.17 | 0.82 ± 0.17 | 0.87 ± 0.19 | 2.02 ± 0.89 | 1.69 ± 0.83 | 1.30 ± 0.62 | 1.86 ± 1.04 | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 33 ± 11 | 24 ± 6 | 27 ± 6 | 32 ± 3 | 24 ± 3 | 14 ± 1* | 17 ± 4 | 31 ± 15 | ||||||
NHB (μmol · kg−1 · min−1) | 1.06 ± 0.38 | 0.60 ± 0.1 | 0.94 ± 0.1 | 1.01 ± 0.08 | 1.10 ± 0.06 | 0.61 ± 0.05 | 0.90 ± 0.15 | 1.00 ± 0.33 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 19 ± 3 | 21 ± 3 | 14 ± 3 | 13 ± 3 | 5 ± 1* | 4 ± 1* | 6 ± 1* | 4 ± 2* | ||||||
NHB (μmol · kg−1 · min−1) | 0.60 ± 0.08 | 0.49 ± 0.04 | 0.54 ± 0.06 | 0.40 ± 0.03 | 0.27 ± 0.07* | 0.24 ± 0.03* | 0.23 ± 0.08* | 0.15 ± 0.07* | ||||||
Glycerol | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 63 ± 4 | 66 ± 5 | 77 ± 5* | 98 ± 12* | 107 ± 15* | 107 ± 12* | 119 ± 5* | 124 ± 11* | ||||||
NHB (μmol · kg−1 · min−1) | −1.12 ± 0.11 | −1.11 ± 0.11 | −1.63 ± 0.11* | −2.34 ± 0.56* | −2.39 ± 0.51* | −2.31 ± 0.43* | −2.68 ± 0.27* | −2.91 ± 0.50* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 88 ± 10 | 68 ± 9 | 57 ± 9 | 78 ± 6 | 92 ± 18 | 88 ± 6 | 105 ± 10 | 108 ± 9 | ||||||
NHB (μmol · kg−1 · min−1) | −2.20 ± 0.28 | −1.42 ± 0.21 | −1.49 ± 0.21 | −2.06 ± 0.34 | −2.60 ± 0.65 | −2.36 ± 0.28 | −2.88 ± 0.46 | −3.34 ± 0.61 | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 85 ± 5 | 74 ± 7 | 98 ± 7 | 73 ± 10 | 96 ± 7 | 92 ± 12 | 70 ± 8 | 78 ± 13 | ||||||
NHB (μmol · kg−1 · min−1) | −1.41 ± 0.14 | −1.29 ± 0.15 | −1.26 ± 0.15 | −1.35 ± 0.17 | −1.68 ± 0.10 | −1.63 ± 0.16 | −1.49 ± 0.19 | −1.45 ± 0.21 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 68 ± 7 | 51 ± 7 | 49 ± 8 | 45 ± 6* | 38 ± 7* | 36 ± 7* | 43 ± 7* | 53 ± 9* | ||||||
NHB (μmol · kg−1 · min−1) | −1.08 ± 0.20 | −0.78 ± 0.20 | −0.79 ± 0.19 | −0.61 ± 0.10 | −0.56 ± 0.04* | −0.52 ± 0.07* | −0.59 ± 0.13* | −0.78 ± 0.18* | ||||||
Lactate | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 632 ± 113 | 595 ± 65 | 522 ± 65 | 573 ± 53 | 479 ± 56 | 461 ± 44* | 467 ± 54* | 452 ± 42* | ||||||
NHB (μmol · kg−1 · min−1) | −1.18 ± 2.76 | −2.08 ± 2.67 | −2.44 ± 2.67 | −4.21 ± 1.78 | −4.37 ± 0.83* | −5.80 ± 1.39* | −7.62 ± 1.24* | −8.73 ± 1.36* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 716 ± 147 | 630 ± 129 | 616 ± 129 | 542 ± 109 | 464 ± 112 | 506 ± 129 | 619 ± 136 | 548 ± 52 | ||||||
NHB (μmol · kg−1 · min−1) | −2.09 ± 1.71 | −2.23 ± 1.19 | −3.84 ± 1.19 | −5.82 ± 2.76* | −5.45 ± 2.44* | −4.80 ± 1.32* | −6.56 ± 1.97* | −8.48 ± 2.22* | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 636 ± 81 | 647 ± 124 | 615 ± 124 | 536 ± 98 | 564 ± 91 | 548 ± 69 | 469 ± 71* | 430 ± 73* | ||||||
NHB (μmol · kg−1 · min−1) | −3.05 ± 2.69 | −1.27 ± 4.15 | −3.71 ± 4.15 | −3.40 ± 3.56 | −1.02 ± 2.23 | −2.44 ± 0.89 | −4.20 ± 0.27 | −5.47 ± 0.42 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 775 ± 120 | 700 ± 120 | 650 ± 80 | 560 ± 60 | 450 ± 40* | 370 ± 20* | 370 ± 30* | 420 ± 40* | ||||||
NHB (μmol · kg−1 · min−1) | 7.73 ± 4.55 | 2.51 ± 5.10 | 0.29 ± 3.24 | 1.99 ± 2.09 | 0.32 ± 1.09* | −0.96 ± 0.92* | −0.91 ± 0.56* | −1.87 ± 0.57* | ||||||
Alanine | ||||||||||||||
Hypoglycemia | ||||||||||||||
Blood level (μmol/l) | 317 ± 21 | 312 ± 21 | 301 ± 21 | 292 ± 13 | 270 ± 29 | 227 ± 27* | 206 ± 26* | 161 ± 26* | ||||||
NHB (μmol · kg−1 · min−1) | −1.99 ± 0.21 | −1.67 ± 0.23 | −2.37 ± 0.23 | −2.71 ± 0.22* | −2.97 ± 0.52* | −2.73 ± 0.36* | −2.97 ± 0.47* | −2.74 ± 0.54* | ||||||
Hypoglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 340 ± 29 | 325 ± 33 | 312 ± 33 | 310 ± 40 | 254 ± 36* | 217 ± 30* | 198 ± 27* | 172 ± 17* | ||||||
NHB (μmol · kg−1 · min−1) | −2.75 ± 0.37 | −2.98 ± 0.58 | −2.79 ± 0.59 | −3.38 ± 0.70 | −3.23 ± 0.88 | −3.05 ± 0.73 | −2.87 ± 0.60 | −2.90 ± 0.52 | ||||||
Euglycemia | ||||||||||||||
Blood level (μmol/l) | 299 ± 25 | 290 ± 25 | 257 ± 25 | 253 ± 28 | 246 ± 25 | 245 ± 27 | 232 ± 35* | 204 ± 34* | ||||||
NHB (μmol · kg−1 · min−1) | −2.31 ± 0.32 | −2.12 ± 0.46 | −1.94 ± 0.46 | −2.33 ± 0.34 | −1.85 ± 0.27 | −2.02 ± 0.51 | −2.20 ± 0.37 | −1.99 ± 0.63 | ||||||
Euglycemia + insulin | ||||||||||||||
Blood level (μmol/l) | 390 ± 45 | 370 ± 50 | 370 ± 50 | 330 ± 40 | 290 ± 30* | 210 ± 20* | 190 ± 20* | 170 ± 20* | ||||||
NHB (μmol · kg−1 · min−1) | −1.93 ± 0.39 | −2.23 ± 0.39 | −2.22 ± 0.41 | −2.04 ± 0.25 | −2.29 ± 0.43 | −1.73 ± 0.26 | −1.67 ± 0.20 | −1.65 ± 0.24 |
Data for each group are means ± SE from five dogs.
Significantly changed from the values during the control period in the same group. Positive and negative values in net hepatic balance (NHB) represent output and uptake rates, respectively.